Many botanical actives are poorly absorbed: curcumin, silymarin, quercetin and boswellic acids are classic examples of compounds that look potent in vitro but barely register in plasma. Delivery technologies exist to close that gap. The two most credible are phytosome and liposomal complexes — different in structure, mechanism and economics.
How each one works
Phytosome
A phytosome is a molecular complex in which the polyphenol is bound to phospholipid (typically phosphatidylcholine) at a defined stoichiometry, usually around 1:1 or 1:2. The phospholipid acts as a chemical chaperone: it improves the active's affinity for the lipid-rich cell membrane and its passage across the gut wall. The active is bonded into the complex, not merely encapsulated.
Liposomal
A liposome is a vesicle — one or more phospholipid bilayers surrounding an aqueous core. The active is physically encapsulated: water-soluble actives sit in the core, lipophilic ones in the bilayer. The vesicle shields the active from gastric degradation and can improve uptake. The trade-off is physical stability: vesicles can leak, fuse or aggregate, so the format demands careful process control and characterisation (particle size, zeta potential, encapsulation efficiency).
Head to head
| Dimension | Phytosome | Liposomal |
|---|---|---|
| Mechanism | Molecular complex with phospholipid | Vesicular encapsulation in a bilayer |
| Best-fit actives | Lipophilic polyphenols (curcumin, silymarin, quercetin) | Both water- and lipid-soluble actives; sensitive molecules |
| Typical bioavailability lift | ~3–7× vs unformulated (active- and study-dependent) | Variable; can be high but depends heavily on quality |
| Physical stability | High — a stable powder, dry-blend friendly | Lower — vesicles can leak/aggregate; favours liquids |
| Format | Free-flowing powder; easy into capsules/tablets | Often liquid/gel; powder versions need robust drying |
| Process complexity | Moderate | High — size and encapsulation must be controlled |
| Cost premium vs standard extract | ~2–4× | ~3–8× (quality-dependent) |
| Characterisation needed | Complex ratio, phospholipid content, assay | Particle size, PDI, zeta potential, encapsulation efficiency |
Choosing for your product
- Lipophilic polyphenol going into a capsule or tablet? Phytosome is usually the pragmatic choice — powder format, strong stability, predictable lift.
- Liquid shot, gummy or beverage, or a fragile/water-soluble active? Liposomal can shine — but insist on encapsulation-efficiency and particle-size data per lot.
- Tight cost ceiling? Phytosome generally carries the lower premium and fewer process risks.
- Label and claim strategy? Both are well recognised; choose the one whose published human data best supports the claim you intend to make.
The wrong question is “which is better?” — the right one is “which solves my active's specific absorption problem at a cost my product can carry?” Match the mechanism to the molecule, then verify the lift with real PK data and verify the lot with real characterisation.
Apply this to your sourcing
Share your specifications — we’ll respond within 24 hours.